Pular para o conteúdo
VuFind
    • English
    • Deutsch
    • Español
    • Français
    • Italiano
    • 日本語
    • Nederlands
    • Português
    • Português (Brasil)
    • 中文(简体)
    • 中文(繁體)
    • Türkçe
    • עברית
    • Gaeilge
    • Cymraeg
    • Ελληνικά
    • Català
    • Euskara
    • Русский
    • Čeština
    • Suomi
    • Svenska
    • polski
    • Dansk
    • slovenščina
    • اللغة العربية
    • বাংলা
    • Galego
    • Tiếng Việt
    • Hrvatski
    • हिंदी
    • Հայերէն
    • Українська
    • Sámegiella
    • Монгол
Avançada
  • Median time to pain improvemen...
  • Citar
  • Enviar por SMS
  • Enviar por e-mail
  • Imprimir
  • Exportar registro
    • Exportar para RefWorks
    • Exportar para EndNoteWeb
    • Exportar para EndNote
  • Link permanente
Median time to pain improvement in patients with psoriatic arthritis treated with tofacitinib

Median time to pain improvement in patients with psoriatic arthritis treated with tofacitinib

Detalhes bibliográficos
Principais autores: de Vlam, K, Ogdie, A, Bushmakin, A, Cappelleri, J, Fleischmann, R, Taylor, P, Azevedo, V, Fallon, L, Maniccia, A, Woolcott, J, Mease, P
Formato: Conference item
Publicado em: Wiley 2018
  • Itens
  • Descrição
  • Registros relacionados
  • Registro fonte

Registros relacionados

  • Median time to pain improvement and the impact of baseline pain severity on pain response in patients with psoriatic arthritis treated with tofacitinib
    por: de Vlam, K, et al.
    Publicado em: (2021)
  • Baseline pain severity as a predictor of pain improvement following treatment with tofacitinib in psoriatic arthritis
    por: Ogdie, A, et al.
    Publicado em: (2018)
  • Understanding mediators of pain reduction in psoriatic arthritis patients treated with tofacitinib: role of inflammation
    por: Taylor, P, et al.
    Publicado em: (2019)
  • Identifying and quantifying the role of inflammation in pain reduction for patients with psoriatic arthritis treated with tofacitinib: a mediation analysis
    por: de Vlam, K, et al.
    Publicado em: (2022)
  • Identifying mediators of pain reduction in patients with psoriatic arthritis treated with tofacitinib: Role of inflammation associated with peripheral arthritis, enthesitis and skin disease
    por: Taylor, PC, et al.
    Publicado em: (2020)

Opções de Busca

  • Histórico de buscas
  • Busca Avançada

Encontrar Mais

  • Navegar o acervo
  • Navegar por ordem alfabética
  • Explorar canais
  • Bibliografia Recomendada
  • Novos itens

Precisa de ajuda?

  • Dicas de Busca
  • Serviço de Referência
  • Perguntas Frequentes